Patents by Inventor Lisa Grace

Lisa Grace has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10471629
    Abstract: An apparatus and process for forming particles.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: November 12, 2019
    Assignee: The Procter & Gamble Company
    Inventors: Richard Albert Huddleston, Lisa Grace Frentzel, Robert Richard Dykstra
  • Patent number: 10301579
    Abstract: A packaged particulate composition having a carrier, perfume, and occlusions of gas.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: May 28, 2019
    Assignee: The Procter & Gamble Company
    Inventors: Robert Richard Dykstra, Lisa Grace Frentzel, Richard Albert Huddleston
  • Publication number: 20180104858
    Abstract: An apparatus and process for forming particles.
    Type: Application
    Filed: December 18, 2017
    Publication date: April 19, 2018
    Inventors: Richard Albert Huddleston, Lisa Grace Frentzel, Robert Richard Dykstra
  • Patent number: 9878467
    Abstract: An apparatus and process for forming particles.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: January 30, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Richard Albert Huddleston, Lisa Grace Frentzel, Robert Richard Dykstra
  • Patent number: 9545460
    Abstract: A process for imparting scent to air comprising the steps of: providing a plurality of particles in a reservoir; heating the reservoir to melt the particles to form a melt; and contacting the melt with air; wherein the particles include polyethylene glycol, perfume, and starch granules and each particle has a mass between about 0.95 mg and about 5 grams.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: January 17, 2017
    Assignee: The Procter & Gamble Company
    Inventors: Lisa Grace Frentzel, Robert Richard Dykstra, Jaden S. Zerhusen, Kathleen Marie Kozak
  • Publication number: 20160368169
    Abstract: An apparatus and process for forming particles.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 22, 2016
    Inventors: Richard Albert HUDDLESTON, Lisa Grace FRENTZEL, Robert Richard DYKSTRA
  • Publication number: 20160369211
    Abstract: A packaged particulate composition having a carrier, perfume, and occlusions of gas.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 22, 2016
    Inventors: Robert Richard DYKSTRA, Lisa Grace FRENTZEL, Richard Albert HUDDLESTON
  • Publication number: 20160175470
    Abstract: A process for imparting scent to air comprising the steps of: providing a plurality of particles in a reservoir; heating the reservoir to melt the particles to form a melt; and contacting the melt with air; wherein the particles include polyethylene glycol, perfume, and starch granules and each particle has a mass between about 0.95 mg and about 5 grams.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 23, 2016
    Inventors: Lisa Grace FRENTZEL, Robert Richard DYKSTRA, Jaden S. ZERHUSEN, Kathleen Marie KOZAK
  • Patent number: 9347022
    Abstract: A composition of a plurality of homogeneously structured particles. The particles include polyethylene glycol, perfume, and starch granules and each has a mass between about 0.95 mg and about 5 grams.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: May 24, 2016
    Assignee: The Procter & Gamble Company
    Inventors: Lisa Grace Frentzel, Robert Richard Dykstra, Jaden S. Zerhusen
  • Publication number: 20120036651
    Abstract: The present invention relates to fabric care compositions that comprise thickeners and the use of fabric care composition in high anionic surfactant conditions.
    Type: Application
    Filed: October 25, 2011
    Publication date: February 16, 2012
    Inventors: Gayle Marie Frankenbach, Alessandro Corona, III, Alice Marie Ward, Sanaul Siddiquee, Yonas Gizaw, Lisa Grace Brush, Geoffrey Marc Wise, Darren Franklin King, Aniesa Parakkat, Jocelyn Michelle McCullough, Walter Augusta Maria Broeckx, Mark Robert Sivik, Jose Andres Rojo Moreno
  • Publication number: 20100098662
    Abstract: The invention relates to the use of 4-[3,5-Bis-(2-hydroxyphenyl)-[1,2,4]-triazol-1-yl]benzoic acid (hereinafter referred to as “Compound I”) for the manufacture of pharmaceutical compositions for the treatment of liver diseases in humans in which iron plays a role in pathogenesis, including viral diseases, such as chronic hepatitis C, optionally in conjunction with antiviral agents and for the treatment of non viral diseases, such as non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Type: Application
    Filed: December 18, 2009
    Publication date: April 22, 2010
    Inventors: Daniele M. Alberti, Peter Marks, Hanspeter Nick, Lisa Grace Rojkjaer
  • Patent number: 7534759
    Abstract: The articles, compositions, and kits of the present invention are useful for conditioning fabric.
    Type: Grant
    Filed: February 16, 2006
    Date of Patent: May 19, 2009
    Assignee: The Procter & Gamble Company
    Inventors: Errol Hoffman Wahl, Jodi Lee Brown, Lisa Grace Brush, Ruth Anne Wagers, George Endel Deckner, Eric Scott Johnson, Barbara Kay Williams, Jiping Wang, Jean-Pol Boutique, Patrick Firmin August Deplancke, Francesco de Buzzaccarini, Michele Ann Watkins
  • Patent number: 7528099
    Abstract: The articles, compositions, and kits of the present invention are useful for conditioning fabric.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: May 5, 2009
    Assignee: The Procter & Gamble Company
    Inventors: Errol Hoffman Wahl, Jodi Lee Brown, Lisa Grace Brush, Ruth Anne Wagers, George Endel Deckner, Eric Scott Johnson, Barbara Kay Williams, Jiping Wang, Jean-Pol Boutique, Patrick Firmin August Deplancke, Francesco de Buzzaccarini, Michele Ann Watkins
  • Publication number: 20080199428
    Abstract: The invention relates to the use of 4-[3,5-Bis-(2-hydroxyphenyl)-[1,2,4]-triazol-1-yl]benzoic acid (hereinafter referred to as “Compound I”) for the manufacture of pharmaceutical compositions for the treatment of liver diseases in humans in which iron plays a role in pathogenesis, including viral diseases, such as chronic hepatitis C, optionally in conjunction with antiviral agents and for the treatment of non viral diseases, such as non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Type: Application
    Filed: May 30, 2006
    Publication date: August 21, 2008
    Inventors: Daniele M. Alberti, Peter Marks, Hanspeter Nick, Lisa Grace Rojkjaer
  • Patent number: 7235518
    Abstract: Fabric conditioning compositions comprising a fabric care active and a hueing dye, wherein the hueing dye exhibits a hueing efficiency of at least about 20 according to the Hueing Efficiency Test method; and a Wash Removal Value from about 50% to about 98%, are useful in mitigating the discoloration of white and other light colored fabrics.
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: June 26, 2007
    Assignee: The Procter & Gamble Company
    Inventors: Lisa Grace Brush, Errol Hoffman Wahl, Jodi Lee Brown, Marena Dessette Brown, Shulin Larry Zhang, Michael David Cummings, Eugene Steven Sadlowski
  • Publication number: 20070105739
    Abstract: The articles, compositions, and kits of the present invention are useful for conditioning fabric.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 10, 2007
    Inventors: Errol Wahl, Jodi Brown, Lisa Grace, Ruth Wagers, George Deckner, Eric Johnson, Barbara Williams, Jiping Wang, Jean-Pol Boutique, Patrick Deplancke, Francesco de Buzzaccarini, Michele Watkins
  • Patent number: 6846477
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: January 25, 2005
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini
  • Publication number: 20040231608
    Abstract: A liquid container combination has a container for retaining a liquid and a strainer disposed within the container. The container has generally vertical side walls and a top wall opening. The strainer is typically disposed below the water level within the container.
    Type: Application
    Filed: May 22, 2003
    Publication date: November 25, 2004
    Inventor: Lisa Grace-Kellogg
  • Publication number: 20030109473
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Application
    Filed: June 19, 2002
    Publication date: June 12, 2003
    Applicant: Pfizer Inc.
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini
  • Patent number: RE44399
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: July 30, 2013
    Assignee: Zoetis LLC
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini